...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >New approach for vertical bone regeneration using in situ in situ gelling and sustained BMP‐2 releasing poly(phosphazene) hydrogel system on peri‐implant site with critical defect in a canine model
【24h】

New approach for vertical bone regeneration using in situ in situ gelling and sustained BMP‐2 releasing poly(phosphazene) hydrogel system on peri‐implant site with critical defect in a canine model

机译:用原位原位胶凝和持续的BMP-2释放聚(磷腈)水凝胶系统在犬植入网站上使用危险缺陷,使用突出骨再生的新方法

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract An injectable hydrogel system with sustained bone morphogenetic protein 2 (BMP‐2) release ability was developed for vertical bone regeneration at peri‐implant sites and enhanced osseointegration of dental implants. In three young male beagle dogs, a pair of defects was created on both sides of the mandibular bone. Next, two implants were transplanted into each defect. In situ gelling polymer solutions with or without BMP‐2 were applied to cover the implants and mandibular defects. The effects of the in situ gelling and sustained BMP‐2 releasing (IGSR) hydrogel system on peri‐implant bone regeneration were evaluated by radiologic examination, micro‐computed tomography, and histomorphometric analysis. Twelve weeks after the treatment, significant bone generation at the peri‐implant site occurred following BMP‐2/IGSR hydrogel treatment. Bone volume and mineral density were increased by 1.7‐ and 1.3‐fold, respectively ( p ??0.01 and 0.05 vs. control, respectively) for the BMP‐2/IGSR hydrogel system. And, 0.57–0.31 mm vertical bone generation was observed at the peri‐implant site for the BMP‐2/IGSR hydrogel system, while rare vertical bone generation occurred in the control group. The BMP‐2/IGSR hydrogel system significantly increased bone to implant contact % between induced bone and existing bone ( p ??0.05 and 0.01 vs. control). These vertical bone regeneration and higher osseointegration levels demonstrated the effectiveness of the BMP‐2/IGSR hydrogel system. ? 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 751–759, 2018.
机译:摘要在PERI-植入部位的垂直骨再生中,开发了一种具有持续骨形态发生蛋白2(BMP-2)释放能力的可注射水凝胶系统,并增强了牙科植入物的骨整合。在三只年轻雄犬狗中,在下颌骨的两侧产生了一对缺陷。接下来,将两个植入物移植到每个缺陷中。施用原位胶凝聚合物溶液或不含BMP-2,以覆盖植入物和下颌缺陷。通过放射学检查,微计算机断层扫描和组织形态分析评估原位胶凝和持续的BMP-2释放(IGSR)水凝胶系统对PERI-植入骨再生的影响。治疗后12周,PERI-植入部位的显着骨骼发生在BMP-2 / IGSR水凝胶处理后发生。骨体积和矿物质密度分别增加1.7-和1.3倍(P 1/10.01&0.05和0.05 Vs.0.05),用于BMP-2 / IGSR水凝胶系统。并且,在PERI-植入部位的BMP-2 / IGSR水凝胶系统中观察到0.57-0.31mm垂直骨产生,而对照组发生罕见的垂直骨产生。 BMP-2 / IGSR水凝胶系统显着增加骨头以植入骨质和现有骨之间的植入接触%(P≤0.05和0.01对照)。这些垂直骨再生和更高的骨整合水平证明了BMP-2 / IGSR水凝胶系统的有效性。还2017年Wiley期刊,Inc。J生物密制Res Part B:苹果生物摩特,106B:751-759,2018。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号